Zimmer Biomet
896 hedge funds and large institutions have $25B invested in Zimmer Biomet in 2019 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 282 increasing their positions, 349 reducing their positions, and 63 closing their positions.
37% more call options, than puts
Call options by funds: $79.1M | Put options by funds: $57.7M
27% more first-time investments, than exits
New positions opened: 80 | Existing positions closed: 63
21% more funds holding in top 10
Funds holding in top 10: 19 → 23 (+4)
16% more capital invested
Capital invested by funds: $21.5B → $25B (+$3.5B)
1% more funds holding
Funds holding: 883 → 896 (+13)
0.59% less ownership
Funds ownership: 91.9% → 91.31% (-0.59%)
19% less repeat investments, than reductions
Existing positions increased: 282 | Existing positions reduced: 349
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$155M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$132M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
+$101M |
| 4 |
HM
HealthCor Management
New York
|
+$96.2M |
| 5 |
Millennium Management
New York
|
+$89.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP
Jana Partners
New York
|
-$143M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$114M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$107M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$99.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$87.9M |
ZBH Hedge Fund Activity: Q3 2019 in Review
896 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2019, worth a combined $25B — up 16% from $21.5B a quarter earlier.
Buyers outnumbered sellers: 80 funds opened new ZBH positions and 63 closed out — a net gain of 17 holders — while 282 added to existing stakes and 349 trimmed.
The largest buyer was Amundi Asset Management US, adding an estimated $155M. The largest seller was Jana Partners, cutting an estimated $143M.
- 896 institutional investors held Zimmer Biomet (ZBH) as of Q3 2019, up from 883 in Q2 2019.
- Funds reported $25B of Zimmer Biomet stock for Q3 2019, up 16% quarter-over-quarter.
- 80 funds opened new Zimmer Biomet positions in Q3 2019 and 63 closed out, a net change of +17 holders.
- The largest Zimmer Biomet buyer in Q3 2019 was Amundi Asset Management US, an estimated $155M added.
- The largest Zimmer Biomet seller in Q3 2019 was Jana Partners, an estimated $143M sold.
Based on aggregated 13F filings for Q3 2019.